Pfizer, Bristol-Myers Blood Thinner Tops Warfarin

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 23 (Bloomberg) -- Pfizer Inc.’s and Bristol-Myers Squibb Co.’s experimental blood thinner apixaban prevented more strokes with less major bleeding than traditional treatment in patients with irregular heartbeats in a key study. Shannon Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change